Elken Healthcare (01789) is now up more than 5%. As of press release, it is up 5.4% to HK$5.27, with a turnover of HK$16.797,900.
The Zhitong Finance App learned that Elken Healthcare (01789) is now up more than 5%. As of press release, it has risen 5.4% to HK$5.27, with a turnover of HK$16.797,900.
According to the news, Elken Medical announced that the company's registration certificate for the three types of medical devices for the knee surgery navigation and positioning system has been approved by the China Drug Administration. The approved product consists of a robotic arm truck, an optical navigator, a trolley, control equipment and accessories. The robotic arm guides knee osteotomy, soft tissue balance, and prosthesis implantation in real time during surgery, bringing more accurate and reliable results to the operation.
CITIC Construction Investment pointed out that at present, the three major segments of orthopedics have all been collected. According to the order of collection and implementation and the extent of price reduction, the joint industry is affected by the collection and clearance rate relatively fast. At present, the penetration rate of joint surgery in China is still low. The company is a leader in the joint field, and is expected to accelerate market share after collection; the company is leading the 3D printing technology industry and continues to increase investment in R&D. Emerging directions such as orthopedic surgery robots and bone biomaterials are expected to drive the company's overall performance growth in the future; after collection, the company has gradually paid attention to overseas layout. Currently, its products have covered more than 30 countries, and its own products have a clear competitive advantage in emerging markets, and the share of overseas business has increased steadily over the past few years.